Skip to main content
OpenTrials

Clinical trial condition

Acute Lung Injury

Explore clinical trials studying Acute Lung Injury. Study availability and eligibility vary by location and protocol.

262 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Acute Lung Injury trial results

Recruiting

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab

NCT06701656

Conditions
ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Lung Injury, +7 more
Locations
  • University of Alabama Hospital Birmingham, Alabama, United States
  • Community Regional Medical Center Fresno, California, United States
  • Long Beach Memorial Medical Center Long Beach, California, United States
  • University of California Irvine Medical Center Orange, California, United States
View all 41 locations
View Trial Details
Recruiting

Effect of EIT-guided PEEP in ARDS Patients

NCT06990477

Conditions
ARDS (Acute Respiratory Distress Syndrome), Acute Lung Injury, Lung Diseases, +2 more
Locations
  • Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Department of Critical Care Medicine, Zhongshan Hospital of Fudan University Shanghai, China Mainland, China
  • Department of Critical Care Medicine, Renji Hospital Shanghai, China Mainland, China
  • The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
View all 17 locations
View Trial Details
Recruiting

Lung EIT Image Guide Ventilation in ARDS

NCT07309783

Conditions
ARDS (Acute Respiratory Distress Syndrome), Acute Lung Injury, Lung Diseases, +2 more
Locations
  • Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
View Trial Details
Recruiting

Lung Injury is One of the Primary Causes of Morbidity and Mortality in Critically Ill Patients. These Patients Will be Monitored for: 1) Immune Cell Activation 2) Blood-based Biomarkers. In Vitro Models Derived From These Samples Will be Treated With Novel Agent PIP-2 to Evaluate Its Efficacy.

NCT07125079

Conditions
ARDS (Acute Respiratory Distress Syndrome), Acute Lung Injury, Lung Diseases, +2 more
Locations
  • Hospital Of the University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions